Mandell GL, Mildvan D. Atlas of Infectious Diseases. 2nd ed. Edinburgh, Scotland: Churchill Livingstone; 1997:chap 12.
Kreiss JK, Kiviat NB, Plummer FA.
et al. Human immunodeficiency virus, human papillomavirus, and cervical intraepithelial
neoplasia in Nairobi prostitutes. Sex Transm Dis.1992;19:54-59.
Wright Jr TC, Ellerbrock TV, Chiasson MA.
et al. for the New York Cervical Disease Study. Cervical intraepithelial neoplasia in women infected with human immunodeficiency
virus. Obstet Gynecol.1994;84:591-597.
Laga M, Icenogle JP, Marsella R.
et al. Genital papillomavirus infection and cervical dysplasia. Int J Cancer.1992;50:45-48.
Marte C, Kelly P, Cohen M.
et al. Papanicolaou smear abnormalities in ambulatory care sites for women
infected with the human immunodeficiency virus. Am J Obstet Gynecol.1992;166:1232-1237.
Chiasson M, Kelley K, Vazquez F.
et al. Incidence of invasive cervical cancer in HIV seropositive women in
New York City. From: 2nd AIDS and Malignancy Conference; April 1998; Bethesda, Md.
Chin KM, Sidhu JS, Janssen RS, Weber JT. Invasive cervical cancer in human immunodeficiency virus-infected and
uninfected hospital patients. Obstet Gynecol.1998;92:83-87.
Maiman M, Fruchter RG, Serur E, Boyce JG. Prevalence of human immunodeficiency virus in a colposcopy clinic. JAMA.1988;260:2214-2215.
Korn AP, Autry M, DeRemer PA, Tan W. Sensitivity of the Papanicolaou smear in human immunodeficiency virus-infected
women. Obstet Gynecol.1994;83:401-404.
Conti M, Agarossi A, Parazzini F.
et al. HPV, HIV infection, and risk of cervical intraepithelial neoplasia
in former intravenous drug abusers. Gynecol Oncol.1993;49:344-348.
Sun XW, Kuhn L, Ellerbrock TV.
et al. Human papillomavirus infection in women infected with the human immunodeficiency
virus. N Engl J Med.1997;337:1343-1349.
Kurman RJ. Blaustein's Pathology of the Female Genital Tract. 4th ed. New York, NY: Springer-Verlag; 1994:229-278.
Sun XW, Ellerbrock TV, Lungu O.
et al. Human papillomavirus infection in human immunodeficiency virus-seropositive
women. Obstet Gynecol.1995;85:680-686.
Lungu O, Wright Jr TC, Silverstein S. Typing of human papillomaviruses by polymerase chain reaction amplification
with L1 consensus primers and RFLP analysis. Mol Cell Probes.1992;6:145-152.
Koulos JP, Wright Jr TC, Mitchell MF.
et al. Relationships between c-Ki-ras mutations, HPV types, and prognostic
indicators in invasive endocervical adenocarcinomas. Gynecol Oncol.1993;48:364-369.
Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance
case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep.1992(RR-17);41:1-19.
Six C, Heard I, Bergeron C.
et al. Comparative prevalence, incidence and short-term prognosis of cervical
squamous intraepithelial lesions amongst HIV-positive and HIV-negative women. AIDS.1998;12:1047-1056.
Tweddel G, Heller P, Cunnane M.
et al. The correlation between HIV seropositivity, cervical dysplasia, and
HPV subtypes 6/11, 16/18, 31/33/35. Gynecol Oncol.1994;52:161-164.
Maiman M, Tarricone N, Vieira J.
et al. Colposcopic evaluation of human immunodeficiency virus-seropositive
women. Obstet Gynecol.1991;78:84.
Maiman M. Management of cervical neoplasia in human immunodeficiency virus-infected
women. J Natl Cancer Inst Monogr.1998;23:43-49.
1999 USPHS/IDSA guidelines for the prevention of opportunistic infections
in persons infected with human immunodeficiency virus. MMWR Morb Mortal Wkly Rep.1999;48(RR-10):1-59,61-66.
Centers for Disease Control and Prevention. 1998 Guidelines for treatment of sexually transmitted diseases. MMWR Morb Mortal Wkly Rep.1998;47(RR-1):1-111.
Koutsky LA, Holmes KK, Critchlow CW.
et al. A cohort study of the risk of cervical intraepithelial neoplasia grade
2 or 3 in relation to papillomavirus infection. N Engl J Med.1992;327:1272-1278.
Rozendaal L, Walboomers JM, van der Linden JC.
et al. PCR-based high-risk HPV test in cervical cancer screening gives objective
risk assessment of women with cytomorphologically normal cervical smears. Int J Cancer.1996;68:766-769.
Ho GY, Bierman R, Beardsley L.
et al. Natural history of cervicovaginal papillomavirus infection in young
women. N Engl J Med.1998;338:423-428.
Wallin KL, Wiklund F, Angstrom T.
et al. Type-specific persistence of human papillomavirus DNA before the development
of invasive cervical cancer. N Engl J Med.1999;341:1633-1638.
Vernon SD, Reeves WC, Clancy KA.
et al. A longitudinal study of human papillomavirus DNA detection in human
immunodeficiency virus type 1-seropositive and -seronegative women. J Infect Dis.1994;169:1108-1112.
Feingold AR, Vermund SH, Burk RD.
et al. Cervical cytologic abnormalities and papillomavirus in women infected
with human immunodeficiency virus. J Acquir Immune Defic Syndr.1990;3:896.
Williams AB, Darragh TM, Vranizan K.
et al. Anal and cervical human papillomavirus infection and risk of anal and
cervical epithelial abnormalities in human immunodeficiency virus-infected
women. Obstet Gynecol.1994;83:205-211.
Wright Jr TC, Sun XW. Anogenital papillomavirus infection and neoplasia in immunodeficient
women. Obstet Gynecol Clin North Am.1996;23:861-893.
Palella Jr FJ, Delaney KM, Moorman AC.
et al. Declining morbidity and mortality among patients with advanced human
immunodeficiency virus infection. N Engl J Med.1998;338:853-860.
Gulick RM, Mellors JW, Havlir D.
et al. Treatment with indinavir, zidovudine, and lamivudine in adults with
human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med.1997;337:734-739.